Sign in

CIK 0001858685

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Biofrontera Inc.

Sign in to watch
Ticker
BFRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473765675
Phone
+1 781-245-1325
Business address
120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-05-18 Monaco Erica L. Chief Executive Officer Option exercise +76,336 133,025
2023-05-18 Monaco Erica L. Chief Executive Officer Option exercise · Restricted Stock Units −76,336 76,336
2022-07-01 Monaco Erica L. Chief Executive Officer Option exercise +56,689 56,689
2022-07-01 Monaco Erica L. Chief Executive Officer Option exercise · Restricted Stock Units −56,689 152,672
2022-05-18 Monaco Erica L. Chief Executive Officer Grant or award · Restricted Stock Units +152,672 209,361
2022-05-18 Monaco Erica L. Chief Executive Officer Grant or award · Employee stock option (right to buy) +152,672 209,361
2021-12-09 Monaco Erica L. Chief Executive Officer Grant or award · Employee stock option (right to buy) +56,689 56,689
2021-12-09 Monaco Erica L. Chief Executive Officer Grant or award · Restricted Stock Units +56,689 56,689
2021-12-09 Monaco Erica L. Chief Executive Officer Grant or award · Employee stock option (right to buy) +56,689 56,689

Page 1 of 1 · 9 trades